Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Arcutis Biotherapeutics, Inc. (ARQT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/31/2023 |
4/A
| Watanabe Todd Franklin (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Granted 87,500 shares
@ $0
Granted 232,000 options to buy
@ $15.82, valued at
$3.7M
|
|
| 08/04/2022 |
4/A
| Turney Patricia A. (SVP, Operations) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Exercised 15,331 options to buy
@ $6.52, valued at
$100k
|
|
| 03/30/2022 |
4/A
| Turney Patricia A. (SVP, Operations) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Exercised 25,328 options to buy
@ $6.52, valued at
$165.1k
|
|
| 07/23/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/23/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/23/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/23/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/23/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/23/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/19/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 05/12/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/07/2021 |
4/A
| Watanabe Todd Franklin (President and CEO) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $28.0754, valued at
$280.8k
Exercised 10,000 options to buy
@ $1.6806, valued at
$16.8k
|
|
| 10/05/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
|
|